News Detail
Maryland, 23 June 2024: The U.S. Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.
Last year, the dr......
View Details
Source : ABC 7
FDA
gene therapy
muscular dystrophy
mmnd
Duchenne Muscular Dystrophy
Related News
- DTAB recommends amendment of Rule 64 related to qualification of competent person (23-10-2024)
- Seven arrested for smuggling prescription medicines sourced from Kerala (23-10-2024)
- ANTF busted Fake medicines factory in Agra, medicines worth Rs 4.5 crore recovered (23-10-2024)
- Six of family killed in Oxygen cylinder blast in Bulandshahr (22-10-2024)
- Gujarat has two new and one upgraded drug testing lab in Surat, Rajkot and Vadodara (22-10-2024)
- Digital transformation of TN DCA increased efficiency: M Sridhar (22-10-2024)
- Oral Semaglutide shows cardio benefits in certain diabetes patients (22-10-2024)
- Waiver of testing requirement for Cough Syrup exports to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland (22-10-2024)
- DTAB agrees with proposal to amend ND&CT Rules to ease registration process of Ethics Committees (21-10-2024)
- Stringent steps needed to keep India label safe from fly-by-night operators (21-10-2024)